瑞迪博士已将阿帕鲁胺进行美国药物主文件备案,这进一步扩展了我们的肿瘤原料药产品系列,并显示了我们在研发和监管事务方面的实力。
我们的原料药合作伙伴现在可以获得美国药物主文件和经过验证的批样品。
发邮件至 [email protected] 或点击下方了解更多:
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.